Status:
TERMINATED
Evaluating Airway Sarcoidosis Pathology With MRI
Lead Sponsor:
Sheffield Teaching Hospitals NHS Foundation Trust
Conditions:
Sarcoidosis
Eligibility:
All Genders
18+ years
Brief Summary
Sarcoidosis is a condition where inflamed cells clump together to form granulomas, which can lead to inflammation or scarring. It can affect any organ of the body, but most commonly affects the lungs....
Eligibility Criteria
Inclusion
- Clinical diagnosis of sarcoidosis
- Sarcoidosis clinician diagnoses airways involvement
- Aged 18 and above
Exclusion
- Current combustible cigarette or electronic cigarette user
- Significant doubt over the diagnosis of sarcoidosis
- Asthma or other airways disease, requiring regular inhaler use
- Contraindication to MRI identified on safety questionnaire
- Recent COVID-19 infection (lateral flow or PCR swab positive within the last 28 days) or ongoing symptoms from COVID-19
Key Trial Info
Start Date :
June 28 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 22 2023
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT05421975
Start Date
June 28 2021
End Date
August 22 2023
Last Update
April 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University MRI Unit
Sheffield, United Kingdom